|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
FY2020
12 months to Oct 3, 2020
|
FY2019
12 months to Sep 28, 2019
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Other loss (income), net | |||||
| Operating (loss) income | |||||
| Interest expense | |||||
| (Loss) earnings before (benefit from) provision for income taxes | |||||
| (Benefit from) provision for income taxes | |||||
| Consolidated (loss) earnings, net | |||||
| Net (loss) income attributable to non-controlling interest | |||||
| Net (loss) earnings attributable to shareholders | |||||
| Basic (loss) earnings per share (in dollars per share) | |||||
| Diluted (loss) earnings per share (in dollars per share) | |||||
| Weighted average number of shares outstanding (in shares) | |||||
| Dilutive effect of stock options and awards (in shares) | |||||
| Weighted average number of shares assuming dilution (in shares) |
Loading...